Volume 15, Issue 4 (1-2020)
J Health Syst Res 2020, 15(4): 304-309 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shokri -Mashhadi N, Mohammadshahi M, Samandari S, Saadat S. The Effect of Astaxanthin Supplementation on Cognitive Function and Depression in Patients with Type 2 Diabetes: A Double-blind, Randomised Controlled Trial. J Health Syst Res 2020; 15 (4) :304-309
URL: http://hsr.mui.ac.ir/article-1-1098-en.html
URL: http://hsr.mui.ac.ir/article-1-1098-en.html
1- Assistant Professor, Department of Clinical Nutrition, School of Nutrition and Food Science, Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2- Assistant Professor, Department of Nutrition, Hyperlipidemia Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3- Psychiatrist of Shahid Modarres Hospital, Isfahan University of Medical Science, Iran
4- Department of Computer Sciences, Faculty of Mathematics and Natural Sciences, Heinrich Heine Universität Düsseldorf, France
2- Assistant Professor, Department of Nutrition, Hyperlipidemia Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3- Psychiatrist of Shahid Modarres Hospital, Isfahan University of Medical Science, Iran
4- Department of Computer Sciences, Faculty of Mathematics and Natural Sciences, Heinrich Heine Universität Düsseldorf, France
Abstract: (1465 Views)
Background: Oral administration of astaxanthin may improve the symptoms of depression and cognitive function through its beneficial effects on inflammation and oxidative stress. This study was conducted to determine the effects of astaxanthin on depressive symptoms and cognitive performance in patients with type II diabetes mellitus.
Methods: This double-blind randomized placebo-controlled clinical study was performed on 44 patients with type II diabetes mellitus aged 30-60 years. The patients were randomized into two groups to receive 8 mg astaxanthin (n=22) or placebo (n=22) daily for 8 weeks. Changes in depression and cognitive performance were assessed by Beck depression Inventory-II (BDI-II) and cognitive functioning questionnaire, respectively.
Findings: After 8 weeks of intervention, the baseline cognitive function score was significantly improved only in the astaxanthin group during the study (P<0.01). However, there was no significant decrease in the BDI-II score in any of the research groups.
Conclusion: As the findings indicated, astaxanthin supplementation in diabetic patients had positive effects on cognitive function over 8 weeks.
Methods: This double-blind randomized placebo-controlled clinical study was performed on 44 patients with type II diabetes mellitus aged 30-60 years. The patients were randomized into two groups to receive 8 mg astaxanthin (n=22) or placebo (n=22) daily for 8 weeks. Changes in depression and cognitive performance were assessed by Beck depression Inventory-II (BDI-II) and cognitive functioning questionnaire, respectively.
Findings: After 8 weeks of intervention, the baseline cognitive function score was significantly improved only in the astaxanthin group during the study (P<0.01). However, there was no significant decrease in the BDI-II score in any of the research groups.
Conclusion: As the findings indicated, astaxanthin supplementation in diabetic patients had positive effects on cognitive function over 8 weeks.
Type of Study: Research |
Subject:
education health and promotion
Received: 2020/07/16 | Accepted: 2020/01/15 | Published: 2020/01/15
Received: 2020/07/16 | Accepted: 2020/01/15 | Published: 2020/01/15
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
